$Lantern Pharma (LTRN.US)$Reuters· 2 mins ago Lantern Pharma & Starlight Therapeutics Present LP-184 (Star-001) Phase 1B Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (Sno) 2024 Highlighting Novel Synthetic Lethality
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more